Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of intravitreous
ranibizumab treatment versus sham injections for prevention of high-risk DR.
Phase:
Phase 3
Details
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators:
Eye & ENT Hospital of Fudan University RenJi Hospital Shanghai 10th People's Hospital Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University Shanghai Tongji Hospital, Tongji University School of Medicine Xinhua Hospital, Shanghai Jiao Tong University School of Medicine